NFKBIZ and neoplasm: After subcutaneous injection of control and IκBζ knockout D4M-3A or YUMM1.7 cells, or control and IκBζ-overexpressing B16-F10 cells into immunocompetent C57BL/6 mice, we monitored tumor growth over time.